Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test
Background: Continuity of care with a regular physician has been associated with treatment adherence but it is unclear if continuity of care may lead to inappropriate treatments. We assessed the relationship between the receipt of prostate-specific antigen (PSA) screening, a non-recommended test, an...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-03-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.622541/full |
| _version_ | 1818736273286758400 |
|---|---|
| author | Arch G. Mainous Arch G. Mainous Benjamin J. Rooks Elvira S. Mercado Peter J. Carek |
| author_facet | Arch G. Mainous Arch G. Mainous Benjamin J. Rooks Elvira S. Mercado Peter J. Carek |
| author_sort | Arch G. Mainous |
| collection | DOAJ |
| description | Background: Continuity of care with a regular physician has been associated with treatment adherence but it is unclear if continuity of care may lead to inappropriate treatments. We assessed the relationship between the receipt of prostate-specific antigen (PSA) screening, a non-recommended test, and having continuity with a single personal doctor.Methods: We analyzed the 2016 and 2018 Behavioral Risk Factor Surveillance System (BRFSS). Responses from men aged 40 and older with no symptoms or family history of prostate cancer were analyzed (unweighted n = 232,548, representing 36,919,766 individuals). Continuity with one doctor was analyzed in relation to discussions of advantages and disadvantages of PSA tests, provider recommendation to receive a test and receipt of a PSA test.Results: 39.5% of men received PSA screening during the time that the test was not recommended. Having a single personal doctor was associated with discussion of both advantages (53.3 vs. 29.7%, p < 0.001) and disadvantages (24.2 vs. 13.5%, p < 0.001) of PSA tests but also a recommendation to receive a PSA test (45.3 vs. 29.3%, p < 0.001). The adjusted odds of receiving a PSA test was higher among those with a single personal doctor compared to those without (OR 2.31; 95% CI, 2.17–2.46).Conclusion: In a nationally representative sample during the time when PSA screening was not recommended by the US Preventive Services Taskforce, having a single personal doctor was associated with both recommendations for the test and receipt of the test. These findings emphasize the importance of the patient physician relationship and the need for evidence-based care. |
| first_indexed | 2024-12-18T00:34:32Z |
| format | Article |
| id | doaj.art-c77e65a3c8bb4326a2053bf267e7e3b5 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-18T00:34:32Z |
| publishDate | 2021-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-c77e65a3c8bb4326a2053bf267e7e3b52022-12-21T21:27:03ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-03-01810.3389/fmed.2021.622541622541Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended TestArch G. Mainous0Arch G. Mainous1Benjamin J. Rooks2Elvira S. Mercado3Peter J. Carek4Department of Community Health and Family Medicine, University of Florida, Gainesville, FL, United StatesDepartment of Health Services Research Management and Policy, University of Florida, Gainesville, FL, United StatesDepartment of Community Health and Family Medicine, University of Florida, Gainesville, FL, United StatesDepartment of Community Health and Family Medicine, University of Florida, Gainesville, FL, United StatesDepartment of Community Health and Family Medicine, University of Florida, Gainesville, FL, United StatesBackground: Continuity of care with a regular physician has been associated with treatment adherence but it is unclear if continuity of care may lead to inappropriate treatments. We assessed the relationship between the receipt of prostate-specific antigen (PSA) screening, a non-recommended test, and having continuity with a single personal doctor.Methods: We analyzed the 2016 and 2018 Behavioral Risk Factor Surveillance System (BRFSS). Responses from men aged 40 and older with no symptoms or family history of prostate cancer were analyzed (unweighted n = 232,548, representing 36,919,766 individuals). Continuity with one doctor was analyzed in relation to discussions of advantages and disadvantages of PSA tests, provider recommendation to receive a test and receipt of a PSA test.Results: 39.5% of men received PSA screening during the time that the test was not recommended. Having a single personal doctor was associated with discussion of both advantages (53.3 vs. 29.7%, p < 0.001) and disadvantages (24.2 vs. 13.5%, p < 0.001) of PSA tests but also a recommendation to receive a PSA test (45.3 vs. 29.3%, p < 0.001). The adjusted odds of receiving a PSA test was higher among those with a single personal doctor compared to those without (OR 2.31; 95% CI, 2.17–2.46).Conclusion: In a nationally representative sample during the time when PSA screening was not recommended by the US Preventive Services Taskforce, having a single personal doctor was associated with both recommendations for the test and receipt of the test. These findings emphasize the importance of the patient physician relationship and the need for evidence-based care.https://www.frontiersin.org/articles/10.3389/fmed.2021.622541/fullcontinuityprostatevaluetrustpatient–doctor relationship |
| spellingShingle | Arch G. Mainous Arch G. Mainous Benjamin J. Rooks Elvira S. Mercado Peter J. Carek Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test Frontiers in Medicine continuity prostate value trust patient–doctor relationship |
| title | Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test |
| title_full | Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test |
| title_fullStr | Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test |
| title_full_unstemmed | Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test |
| title_short | Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test |
| title_sort | patient provider continuity and prostate specific antigen testing impact of continuity on receipt of a non recommended test |
| topic | continuity prostate value trust patient–doctor relationship |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2021.622541/full |
| work_keys_str_mv | AT archgmainous patientprovidercontinuityandprostatespecificantigentestingimpactofcontinuityonreceiptofanonrecommendedtest AT archgmainous patientprovidercontinuityandprostatespecificantigentestingimpactofcontinuityonreceiptofanonrecommendedtest AT benjaminjrooks patientprovidercontinuityandprostatespecificantigentestingimpactofcontinuityonreceiptofanonrecommendedtest AT elvirasmercado patientprovidercontinuityandprostatespecificantigentestingimpactofcontinuityonreceiptofanonrecommendedtest AT peterjcarek patientprovidercontinuityandprostatespecificantigentestingimpactofcontinuityonreceiptofanonrecommendedtest |